- DKK11.91bn
- DKK11.62bn
- DKK511.06m
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation
Brief: Chemometec Says Blackrock Increases Voting Rights In Chemometec To 15.08% On Sept 29, 2026
Brief: Chemometec Raises 2026/27 Revenue, EBITDA Guidance
Brief: Chemometec Completes Share Buyback Programme
Denmark's ChemoMetec annual revenue rises on new instrument demand, services growth
Brief: Chemometec FY EBITDA DKK 281.3 Million
Brief: Chemometec A/S Says Expects Fy2026/27 Revenue Of DKK 545-575 Million
Brief: Chemometec Enters Collaboration Deal With Roche Diagnostics
Brief: Chemometec A/S Appoints Phillip Massie Price As CFO Effective 3 August 2026
Brief: Chemometec Starts Buy-Back Programme
Denmark's ChemoMetec Q3 revenue rises
Brief: Chemometec Q3 EBITDA DKK 84.5 Million
Brief: Chemometec Upgrades FY Revenue, EBITDA Guidance
Europe Research Roundup: HBX Group, Ipsen, Knorr Bremse
Brief: Chemometec Cuts FY EBITDA Outlook To DKK 260-285 Million
Europe Research Roundup: Airbus, Nestlé, VAR Energi